Lineage Cell Therapeutics, Inc. Skyrocketed
Tue, Apr 27, 2021 at 05:30 PM
Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT) soared at $24.9, a gain of 51.2%. On Mon, Apr 26, 2021, BTX:NYSEMKT touched a New 2-Week High of $16.47. The stock got featured on our News Catalysts scanner on Mon, Apr 26, 2021 at 08:48 AM in the 'MISCELLANEOUS' category. From Mon, Apr 12, 2021, the stock recorded 70.00% Up Days and 54.55% Green Days
About Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT)
BioTime Inc focuses regenerative medicine technologies in ophthalmology, soft tissue reconstruction, and the local delivery of cells and therapeutics.
Top 10 Gainers:
- TerraForm Global, Inc. (GLBL:NASDAQ), 100%
- Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT), 51.18%
- Urban Tea, Inc. (MYT:NASDAQ), 38.1%
- Vaxart, Inc. (VXRT:NASDAQ), 37.46%
- TIRX (TIRX:NASDAQ), 36.27%
- Aldeyra Therapeutics, Inc. (ALDX:NASDAQ), 33.66%
- RiceBran Technologies (RIBT:NASDAQ), 26.88%
- NetSol Technologies, Inc. (NTWK:NASDAQ), 25.29%
- TrueBlue, Inc. (TBI:NYSE), 24.89%
- EEIQ (EEIQ:NASDAQ), 21.23%